Nasdaq:US$14.91 (-0.25) | HKEX:HK$23.20 (-0.30) | AIM:£2.30 (+0.05)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 其他業務 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture